Business, energy, technology, markets and global industry news from Business News Today

solid tumours

PharmaDeviceNews solid tumours
Representative image: Researchers use artificial intelligence and machine learning to design tumour-targeting multispecific antibodies, reflecting the LabGenius Therapeutics and LG Chem collaboration aimed at improving precision and safety in solid tumour treatment.
Pharma & Biotech

LabGenius-LG Chem deal tests whether AI can improve solid-tumour treatment precision

Discover how LabGenius and LG Chem aim to use AI-designed multispecific antibodies to reduce solid-tumour toxicity and reshape oncology R&D.

Read More
Pharma & Biotech

How Full-Life Technologies is using US$150m to push beyond platform promise

Radiopharma needs more than promising targets. Full-Life’s US$150m raise puts actinium-225 supply and clinical execution in focus.

Read More
Pharma & Biotech

Why Norgine’s PEDMARQSI approval in Switzerland could reshape cisplatin ototoxicity management

Swissmedic approved PEDMARQSI for cisplatin-related hearing loss in children. Read why this could reshape paediatric oncology supportive care.

Read More
Representative image of scientists evaluating next-generation Claudin-6-targeted cell therapy research as OverT Bio advances OVT-101 toward ovarian cancer clinical development.
Pharma & Biotech

OverT Bio moves OVT-101 closer to clinic as solid tumour cell therapy race intensifies

OverT Bio is advancing OVT-101 toward the clinic in ovarian cancer. Read what its new advisory board could change for solid tumour cell therapy.

Read More